D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 108 Citations 58,165 446 World Ranking 204 National Ranking 138
Medicine D-index 139 Citations 94,951 900 World Ranking 694 National Ranking 418

Research.com Recognitions

Awards & Achievements

2000 - IEEE Fellow For the introduction of fundamental concepts and methodology in the Bayesian approach to computer vision and on unsupervised statistical machine learning.

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

David A. Cooper mostly deals with Immunology, Internal medicine, Virology, Acquired immunodeficiency syndrome and Viral load. David A. Cooper interconnects Lipodystrophy, Endocrinology, Surgery, Zidovudine and Gastroenterology in the investigation of issues within Internal medicine. His work in Lipodystrophy tackles topics such as Lipoatrophy which are related to areas like Outpatient clinic.

David A. Cooper has researched Endocrinology in several fields, including Protease inhibitor and HIV-associated lipodystrophy. His research investigates the link between Acquired immunodeficiency syndrome and topics such as Cohort study that cross with problems in Cohort. His study in Viral load is interdisciplinary in nature, drawing from both Clinical trial, Regimen, Adverse effect, Pharmacotherapy and Raltegravir.

His most cited work include:

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. (2105 citations)
  • CD4+ count-guided interruption of antiretroviral treatment. (1814 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Immunology, Internal medicine, Virology, Acquired immunodeficiency syndrome and Viral load. His study in Viral disease, Immune system, Immunopathology, T cell and CD8 is carried out as part of his studies in Immunology. His Internal medicine research integrates issues from Gastroenterology, Surgery and Zidovudine.

His studies in Virology integrate themes in fields like Cytotoxic T cell, Antibody and Antigen. In his research, Cohort study is intimately related to Cohort, which falls under the overarching field of Acquired immunodeficiency syndrome. In his study, Integrase inhibitor is strongly linked to Raltegravir, which falls under the umbrella field of Viral load.

He most often published in these fields:

  • Immunology (41.78%)
  • Internal medicine (36.90%)
  • Virology (30.31%)

What were the highlights of his more recent work (between 2012-2021)?

  • Immunology (41.78%)
  • Internal medicine (36.90%)
  • Virology (30.31%)

In recent papers he was focusing on the following fields of study:

His main research concerns Immunology, Internal medicine, Virology, Viral load and Randomized controlled trial. Immunology is often connected to Cohort in his work. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Raltegravir, Pharmacology and Ritonavir.

David A. Cooper combines subjects such as Antibody and Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019 with his study of Virology. His work in Viral load addresses issues such as Proportional hazards model, which are connected to fields such as Hazard ratio. His Randomized controlled trial research includes themes of Physical therapy and Adverse effect.

Between 2012 and 2021, his most popular works were:

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. (387 citations)
  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. (341 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Cancer

David A. Cooper spends much of his time researching Immunology, Virology, Internal medicine, Viral load and Randomized controlled trial. His Immunology course of study focuses on Cohort and Cd4 cell count. His Virology research includes elements of Epitope, Reverse transcriptase, B cell and Severe acute respiratory syndrome coronavirus 2.

The various areas that David A. Cooper examines in his Internal medicine study include Raltegravir, Placebo and Pharmacology. He works mostly in the field of Pharmacology, limiting it down to concerns involving Efavirenz and, occasionally, Pharmacokinetics and Gastroenterology. His work carried out in the field of Viral load brings together such families of science as Young adult, Demography, Proportional hazards model, Seroconversion and Emtricitabine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)

3959 Citations

CD4+ count-guided interruption of antiretroviral treatment.

Wafaa El-Sadr;Wafaa El-Sadr;Jens D Lundgren;James Neaton;Fred Gordin.
The New England Journal of Medicine (2006)

2986 Citations

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Andrew Carr;Katherine Samaras;Samantha Burton;Matthew Law.
AIDS (1998)

2897 Citations

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

Andrew Carr;Katherine Samaras;Anna Thorisdottir;Gilbert R Kaufmann.
The Lancet (1999)

1847 Citations

Adverse effects of antiretroviral therapy

Andrew Carr;David A Cooper;David A Cooper.
The Lancet (2000)

1480 Citations

Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel

Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell.
JAMA (2000)

1369 Citations

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

Andrew Carr;Katherine Samaras;Donald J Chisholm;David A Cooper.
The Lancet (1998)

1290 Citations

Acute AIDS Retrovirus Infection. Definition of a Clinical Illness Associated With Seroconversion

DavidA. Cooper;DavidA. Cooper;DavidA. Cooper;Prudence Maclean;Prudence Maclean;Prudence Maclean;Robert Finlayson;Robert Finlayson;Robert Finlayson;HarryM. Michelmore;HarryM. Michelmore;HarryM. Michelmore.
The Lancet (1985)

1064 Citations

A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients: The INCAS Trial

Julio S. G. Montaner;Peter Reiss;David Cooper;Stefano Vella.
JAMA (1998)

974 Citations

Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel

Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper.
JAMA (2002)

965 Citations

Best Scientists Citing David A. Cooper

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 204

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 203

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 196

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 174

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 160

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 157

Peter Reiss

Peter Reiss

University of Amsterdam

Publications: 154

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 152

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 146

Caroline Sabin

Caroline Sabin

University College London

Publications: 144

Dominique Costagliola

Dominique Costagliola

Université Paris Cité

Publications: 141

Adriano Lazzarin

Adriano Lazzarin

Vita-Salute San Raffaele University

Publications: 140

Matthew Law

Matthew Law

UNSW Sydney

Publications: 128

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 123

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 122

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.